A multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Sentagliptin combined with metformin in the treatment of patients with type 2 diabetes
Latest Information Update: 09 Dec 2024
At a glance
- Drugs Cetagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Dec 2024 According to a CGeneTech media release, company announced that National Medical Products Administration (NMPA) of China announced that Sengagliptin phosphate tablets (formerly known as saxagliptin phosphate tablets), has been approved for market in China based on the results of phase 3 study.
- 05 Dec 2024 Results presented in a CGeneTech Media Release.
- 20 Mar 2024 New trial record